Pharmaceutical dosages delivery system

Abstract

Pharmaceutical delivery systems for delivering dosages according to the present invention include a carrier component and a cap configured to seal an internal volume of the carrier component, wherein the cap includes a device that produces a unique current signature. Dosages prepared to be delivered according to embodiments of the invention find use in a variety of different applications, including clinical trials.

Description

CROSS-REFERENCE[0001]Pursuant to 35 U.S.C. §119 (e), this application claims priority to the filing date of U.S. Provisional Patent Application Ser. No. 61 / 142,861 filed on Jan. 6, 2009, the disclosure of which application is herein incorporated by reference. This application also claims the benefit of PCT Application No. PCT / US10 / 20140 of the same title filed on Jan. 5, 2010, which is herein incorporated by reference.FIELD OF THE INVENTION[0002]This invention relates generally to electronic devices and, more specifically, to electronic devices that are part of a communication system that uses conduction to communicate information.INTRODUCTION[0003]Prescription medications are effective remedies for many patients when taken properly. However, studies show that on average, about 50% of patients do not comply with prescribed medication regimens. A low rate of adherence with medication regimens results in a large number of hospitalizations and admissions to nursing homes every year. In...

AI Technical Summary

Benefits of technology

The invention allows pharmaceutical dosages to be prepared using standard components and customized with different active agents. This is beneficial for clinical trials, as it allows trial managers to easily modify the components to meet the needs of the trial.

Problems solved by technology

However, studies show that on average, about 50% of patients do not comply with prescribed medication regimens.

A low rate of adherence with medication regimens results in a large number of hospitalizations and admissions to nursing homes every year.

In the United States alone, it has recently been estimated that costs resulting from patient non-adherence amount to over $100 billion annually.

Such an elevated dose could cause a higher incidence of side effects, which in turn may lead to further non-adherence.

Images